Latamoxef Impurity 30 CAS CATO-C4X-179830
| CAS No. | CATO-C4X-179830 |
| Molecular Formula | C9H10N2O5 |
| Molecular Weight | 226.19 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
The molecular framework of Latamoxef Impurity 30 (C9H10N2O5) is characterized by an amino-acid-derived structure, an amide group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
CATO supplies Latamoxef Impurity 30 (CAS CATO-C4X-179830), a pharmacopoeial impurity reference standard (molecular formula C9H10N2O5, MW 226.19 g/mol) used for the identification and quantification of trace impurities in APIs.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
Physical & Chemical Properties
| Molecular Formula | C9H10N2O5 |
| Molecular Weight | 226.19 g/mol |
| Appearance | Off-white to pale yellow crystalline powder. (faint amine-like odor) |
| Purity | 95% |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in methanol, ethanol, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 6.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Nitrogen Atoms | 2 |
Related Latamoxef Standards
- Latamoxef Impurity 39 (CAS CATO-C4X-179839)
- Latamoxef Impurity 49 (CAS CATO-C4X-179849)
- Latamoxef Impurity 8 (CAS 64076-52-4)
- Latamoxef Impurity 35 (CAS CATO-C4X-179835)
- Latamoxef Impurity 6 (CAS 78641-40-4)
- Latamoxef Impurity 37 (CAS CATO-C4X-179837)
- Latamoxef Impurity 29 (CAS CATO-C4X-179829)
- Latamoxef Impurity 45 (CAS CATO-C4X-179845)
Recommended Standards
- Doxofylline Impurity 35 (CAS CATO-C4X-151335)
- Furazolidone Impurity 1 (CAS CATO-C4X-29011)
- Doxofylline Impurity 33 (CAS CATO-C4X-151333)
- Cinitapride Impurity 24 (CAS 2384085-43-0)
- Famciclovir Impurity 36 (CAS 172645-79-3)
- Levocarnitine Impurity 39 (CAS 1809158-58-4)
- CAS 30718-13-9 (CAS 30718-13-9)
- 3-[5-(1,5-dimethyl-1h-pyrazol-4-yl)-7-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]propanoic acid (CAS 1174878-30-8)
- tert-butyl (4S)-4-(methoxymethyl)-2,2-dioxo-oxathiazolidine-3-carboxylate (CAS 2023006-41-7)
- 5-(1h-Pyrazol-3-yl)-1,2,4-oxadiazole-3-carboxylic acid (CAS 1339857-20-3)
- 1-(5-Amino-1H-pyrazol-4-yl)propan-1-one (CAS 77798-50-6)
- 2-((P-tolylthio)methyl)-1H-benzo[d]imidazole (CAS 324774-00-7)
- 2-Fluoro-4-(pyrrolidin-1-ylmethyl)phenol (CAS 1260750-79-5)
- Uremic Pentapeptide (CAS 71494-20-7)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com